TRV GP II, LLC

Holdings History for Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

Symbol: SAGE
Investment type: Equity / Common Stock, par value $0.0001 per share (the "Common Stock")

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2019		-3.6%	$0	0	-37,362	-100%	$14.85	Q1 2019
31 Dec 2018	3.6%	0%	$3,579,000	37,362	0		$95.79	Q4 2018
30 Sep 2018	3.1%	0%	$5,277,000	37,362	0		$141.24	Q3 2018
30 Jun 2018	3.3%	0%	$5,848,000	37,362	0		$156.52	Q2 2018
31 Mar 2018		0%	$6,018	37,362	0		$0.16 ^*	Q1 2018
31 Dec 2017	16%	0%	$90,247,000	547,916	0		$164.71	Q4 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.